中文 | English
Return
Total: 1420 , 1/142
Show Home Prev Next End page: GO
Author:(Hui Ding)

1.Secondary resistance of gefitinib in non-small-cell lung cancer treatment

Hui JI ; Cuimin DING

Journal of International Oncology 2008;35(12):908-910

2.Progress in animal models for predicting the results of clinical trials of cancer drugs

Fei YU ; Hui DING

Chinese Journal of Comparative Medicine 2015;(6):65-69,70

3.Biological characteristics and clinical implications of CALR mutations in classic myeloproliferative neoplasms

Wuhan HUI ; Ding TIAN

Journal of Leukemia & Lymphoma 2015;24(7):420-423,427

4.Airway stents in children

Hui DING ; Xicheng LIU

Chinese Journal of Applied Clinical Pediatrics 2015;30(16):1204-1206

5.Analysis on residents′knowledge and satisfaction of equalization policies on basic public health services in five districts of gansu

Hui LIU ; Guowu DING

Chongqing Medicine 2016;45(11):1539-1541

6.Study of risk factors of type 2 diabetes mellitus patients complicated with cerebral infarction

Hui ZHAO ; Suju DING

Journal of Clinical Neurology 1997;0(06):-

7.Application of HL-K rigid gas permeable contact lens for keratoconus

Hui DING ; Xingwu ZHONG

Recent Advances in Ophthalmology 2017;37(9):849-852

8.Rehabilitation outcome and influencing factors of functional recovery in patients with nontraumatic spinal cord injury

Xiaobing DU ; Yaping DING ; Hui DING ; Li ZHOU ; Ping LIU

Chinese Journal of Practical Nursing 2017;33(14):1067-1071

9.Comparison of tamsulosin versus nifedipine for the management of lower ureteral stones

Jiaju LU ; Lijing WEI ; Hui ZHANG ; Sentai DING ; Kejia DING

Chinese Journal of Urology 2001;0(09):-

10.Influence of Urapidil at Different Doses on Blood Pressure and Prognosis after Thrombolsis with Urokinase Patients with Acute Ischemic Stroke

Yingying XUAN ; Yun DING ; Hui WANG

China Pharmacist 2017;20(7):1250-1252

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1420 , 1/142 Show Home Prev Next End page: GO